If you purchased
Magenta Therapeutics, Inc. securities and would like to join the action, please click "Join This Action" below.
We would handle the action on a contingent fee basis, whereby you would not be responsible for payment of our legal fees or expenses in the action.
MGTA STOCK ALERT: HALPER SADEH LLC IS INVESTIGATING WHETHER THE MERGER OF MAGENTA THERAPEUTICS, INC. IS FAIR TO SHAREHOLDERS
May 3, 2023.
New York, New York—Halper Sadeh LLC, an investor rights law firm, is investigating whether the merger of Magenta Therapeutics, Inc. (NASDAQ: MGTA) and Dianthus Therapeutics, Inc. is fair to Magenta shareholders. Upon completion of the proposed transaction, Magenta shareholders are expected to own approximately 21.3% of the combined company.
The investigation concerns whether Magenta and its board violated the federal securities laws and/or breached their fiduciary duties to shareholders by failing to, among other things: (1) obtain the best possible consideration for Magenta shareholders; and (2) disclose all material information necessary for Magenta shareholders to adequately assess and value the merger consideration. On behalf of Magenta shareholders, Halper Sadeh LLC may seek increased consideration for shareholders, additional disclosures and information concerning the proposed transaction, or other relief and benefits.
Halper Sadeh LLC represents investors all over the world who have fallen victim to securities fraud and corporate misconduct. Our attorneys have been instrumental in implementing corporate reforms and recovering millions of dollars on behalf of defrauded investors.
Attorney Advertising. Prior results do not guarantee a similar outcome.